tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ATRA Stock Latest News

Atara Biotherapeutics price target lowered to $2.30 from $4.80 at Stifel
The FlyAtara Biotherapeutics price target lowered to $2.30 from $4.80 at Stifel
18d ago
ATRA
Atara Biotherapeutics Board Member Decides Not to Seek Re-Election
PremiumCompany Announcements
Atara Biotherapeutics Board Member Decides Not to Seek Re-Election
21d ago
8K
ATRA
Atara Biotherapeutics’ Profitability Hinges on Partners’ Success with Ebvallo Amid Market Challenges
PremiumCompany Announcements
Atara Biotherapeutics’ Profitability Hinges on Partners’ Success with Ebvallo Amid Market Challenges
21d ago
ATRA
FDA clears Atara’s IND application in LN for allogeneic CAR T therapy ATA3219
PremiumThe Fly
FDA clears Atara’s IND application in LN for allogeneic CAR T therapy ATA3219
2M ago
ATRA
ATRA Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ATRA Upcoming Earnings Report: What to Expect?
2M ago
ATRA
Atara Biotherapeutics Restructures, CMO Transitions to Consultant
PremiumCompany AnnouncementsAtara Biotherapeutics Restructures, CMO Transitions to Consultant
2M ago
8K
ATRA
Atara Biotherapeutics submits IND for ATA3219 to treat Lupus Nephriti
PremiumThe Fly
Atara Biotherapeutics submits IND for ATA3219 to treat Lupus Nephriti
2M ago
ATRA
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
ADVM
ATRA
Atara Biotherapeutics, Pierre Fabre announce publication of ALLELE data
PremiumThe Fly
Atara Biotherapeutics, Pierre Fabre announce publication of ALLELE data
3M ago
ATRA
Atara Biotherapeutics’ tabelecleucel meets primary endpoint in Phase 3 study
PremiumThe Fly
Atara Biotherapeutics’ tabelecleucel meets primary endpoint in Phase 3 study
3M ago
ATRA
Atara Biotherapeutics sells 27.272M shares at 55c in registered direct offering
PremiumThe Fly
Atara Biotherapeutics sells 27.272M shares at 55c in registered direct offering
3M ago
ATRA
Atara Biotherapeutics announces $15M registered direct offering
PremiumThe Fly
Atara Biotherapeutics announces $15M registered direct offering
3M ago
ATRA
Atara Biotherapeutics presents ‘positive’ preclinical data on ATA3431 at ASH
PremiumThe FlyAtara Biotherapeutics presents ‘positive’ preclinical data on ATA3431 at ASH
4M ago
ATRA
Atara Biotherapeutics to present ‘positive’ tab-cel data during ESMO session
PremiumThe Fly
Atara Biotherapeutics to present ‘positive’ tab-cel data during ESMO session
5M ago
ATRA
Atara Biotherapeutics price target lowered to 40c from $1.40 at Citi
PremiumThe Fly
Atara Biotherapeutics price target lowered to 40c from $1.40 at Citi
5M ago
ATRA
Atara Biotherapeutics downgraded to In Line from Outperform at Evercore ISI
PremiumThe Fly
Atara Biotherapeutics downgraded to In Line from Outperform at Evercore ISI
5M ago
ATRA
Atara Biotherapeutics price target lowered to $13 from $19 at Canaccord
PremiumThe Fly
Atara Biotherapeutics price target lowered to $13 from $19 at Canaccord
5M ago
ATRA
Atara Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Atara Biotherapeutics downgraded to Neutral from Buy at H.C. Wainwright
5M ago
ATRA
Atara Biotherapeutics downgraded to Neutral from Buy at Mizuho
PremiumThe Fly
Atara Biotherapeutics downgraded to Neutral from Buy at Mizuho
5M ago
ATRA
Atara Biotherapeutics trading resumes
PremiumThe FlyAtara Biotherapeutics trading resumes
5M ago
ATRA
Atara Biotherapeutics’ ATA188 did not meet primary endpoint in sclerosis trial
PremiumThe Fly
Atara Biotherapeutics’ ATA188 did not meet primary endpoint in sclerosis trial
5M ago
ATRA
Atara Biotherapeutics trading halted, news pending
PremiumThe Fly
Atara Biotherapeutics trading halted, news pending
5M ago
ATRA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >